Pre-Implantation Genetic Diagnosis Provides Options
Men and women who carry genes for inherited genetic disorders now have options to avoid passing along genetic abnormalities to their children. The University of Michigan’s Center for Reproductive Medicine offers pre-implantation genetic diagnosis (PGD) to identify genetic disorders like cystic fibrosis, Betathalassemia, sickle cell disease, spinal muscular atrophy, myotonic dystrophy, Huntington’s disease, Fragile X syndrome and Duchenne muscular dystrophy.
PGD is used in conjunction with in vitro fertilization. Embryos are tested to determine if they carry a genetic abnormality, and only embryos without genetic defects are implanted in the womb.
PGD is also used to screen for chromosomal abnormalities - specifically translocations, when a section of a chromosome is attached to another chromosome. If a couple is interested in PGD, they will want to talk to their insurance provider. In most cases, PGD is not covered by insurance.
The Center for Reproductive Medicine is a leader in fertility services in the state of Michigan. Women benefit from access to a multi-disciplinary team.
To learn more about pre-implantation genetic diagnosis, contact the University of Michigan Center for Reproductive Medicine by e-mail: obgyn-UM-CRM@med.umich.edu or phone: 734-763-4323.